- Home
- BKH vs AXSM Comparison
BKH vs AXSM Comparison
Compare BKH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKH | AXSM |
|---|---|---|
| Founded | 1941 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 7.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BKH | AXSM |
|---|---|---|
| Price | $69.31 | $154.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 20 |
| Target Price | $71.00 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 1.1M | 479.3K |
| Earning Date | 02-04-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.91% | N/A |
| EPS Growth | ★ 7.21 | N/A |
| EPS | ★ 3.95 | N/A |
| Revenue | ★ $2,271,600,000.00 | $561,263,000.00 |
| Revenue This Year | $10.35 | $66.40 |
| Revenue Next Year | $3.07 | $56.13 |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | 7.04 | ★ 65.83 |
| 52 Week Low | $54.92 | $75.56 |
| 52 Week High | $74.02 | $158.57 |
Technical Indicators
Market Signals| Indicator | BKH | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 48.44 | 62.63 |
| Support Level | $67.25 | $152.41 |
| Resistance Level | $73.09 | $158.56 |
| Average True Range (ATR) | 1.38 | 4.21 |
| MACD | -0.48 | 0.15 |
| Stochastic Oscillator | 37.67 | 66.19 |
Price Performance
Historical ComparisonAbout BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.